Ticker Scorecard - ANIK Basics Company: Anika Therapeutics Inc. IPO Date: January 3, 1994 Sector: Healthcare Industry: Biotech Market Cap: $261.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 1.98% Avg Daily Range (30 D): $0.27 | 1.65% Avg Daily Range (90 D): $0.34 | 1.72% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 41 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 1,252 Avg Inst. Trade: $1.25M Avg Inst. Trade (30 D): $1.27M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $1.27M Avg Closing Trade (90 D): $1.27M Avg Closing Volume: 33.12K     News Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research Oct 17, 2024 @ 8:01 PM Anika Announces Third Quarter 2024 Results Confere... Source: N/A Aug 15, 2024 @ 8:01 PM Anika Reports Inducement Grants Under Nasdaq Listi... Source: N/A Jun 7, 2024 @ 8:01 PM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Anika Therapeutics Inc. May 29, 2024 @ 4:00 PM Peeling Back The Layers: Exploring Anika Therapeut... Source: Benzinga Insights Financials   TTM Q3 2024 Q2 2024 Basic EPS $-6.64 $-2.03 $-.01 Diluted EPS $-6.64 $-2.03 $-.01 Revenue $ 164.17M $ 38.75M $ 41.92M Gross Profit $ 79.76M $ 1.44M $ 27.37M Net Income / Loss $ -97.52M $ -29.92M $ -.09M Operating Income / Loss $ -96.7M $ -28.02M $ .16M Cost of Revenue $ 84.41M $ 37.31M $ 14.56M Net Cash Flow $ -8.44M $ -.79M $ -5.58M PE Ratio